Cancer in 2025: Funding, New Treatments, and Breakthrough Ideas
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
The American Association for Cancer Research (AACR) wrapped up National Cancer Research Month by inviting a group of 50...
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
Today is National “Don’t Fry Day,” an initiative undertaken by the National Council on Skin Cancer Prevention to encourage...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
May is National Cancer Research Month, and for the past 10 years, leaders and members from the American Association...
In recent years, the American Association for Cancer Research (AACR) has expanded its efforts to catalyze advances in cancer...
A study published recently in the AACR’s journal Cancer Discovery addresses the burgeoning question of the utility of high-throughput...
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
After being diagnosed with cancer, some patients consider getting a second opinion. This may involve a pathologist confirming a...